Erica Rice

Representative Experience

• Represented Shift4 Payments (NYSE: FOUR) in connection with its acquisition of 3dcart 
• Represented AZTherapies, Inc. in its $33.6 million Series C-1 financing 
• Represented Ascend Wellness Holdings, a multi-state, vertically integrated cannabis operator, in the acquisition of Greenleaf Compassion Center, a New Jersey vertically integrated cannabis company
• Advised global cannabis operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in its pending acquisition of The Green Solution (“TGS”), the largest vertically integrated cannabis operator in Colorado, through a transaction initially valued at approximately $140 million  
• Represented digital financial company BlockFi, Inc. in closing its $37M Series B financing 
• Represents numerous early stage companies in seed stage and venture financing transactions, including BlockFi, Pear Therapeutics, InsightSquared, MiniLuxe, American Aerogel Corporation, Senti Biosciences and Glympse Bio
• Represents numerous venture capital firms, including Accomplice, Cue Ball Capital, Safeguard Scientifics and Flagship Pioneering, in their portfolio investment activities
• Represented LevelUp, a leader in mobile diner engagement and payment solutions for restaurants, in its $390M sale to online and mobile food-ordering and delivery marketplace Grubhub Inc.
• Represented mobile-focused voting and citizen engagement platform Voatz in its $7 million Series A financing
• Represented global cybersecurity leader RSA in its acquisition of Fortscale
• Represented Orig3n in its acquisition of Interleukin Genetics
• Represented L2, Inc. in its acquisition by Gartner, Inc.
• Represented Thermo Fisher Scientific in its acquisition of MTI-GlobalStem
• Represented CloudLock in its acquisition by Cisco
• Represented Pegasystems in its acquisition of OpenSpan
• Represented Resilient Systems in its acquisition by IBM
• Represented Litmus in its $49 million investment from Spectrum Equity
• Represented Viewfinity in its acquisition by CyberArk
• Represented EMC Corporation in numerous mergers and acquisitions
• Represented Applied Genetic Technologies Corporation in $52 million initial public offering and subsequent $30 million follow-on public offering